Skip to main content
. 2016 Aug 19;5(9):e1214788. doi: 10.1080/2162402X.2016.1214788

Figure 1.

Figure 1.

Summary of treatment schedules received by patients receiving extracranial RT or SRS. Patients received radiotherapy either (A) sequentially (commenced and competed within 28 d prior to starting anti-PD-1 antibody), (B) concurrently with anti-PD-1 antibody, or (C) for clinical or radiological progression noted more than six weeks after starting anti-PD-1 antibody.